Lantronix, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Lantronix, Inc. on May 14, 2012. The filing addresses significant corporate governance changes involving the Board of Directors and the resulting impact on the company's compliance with NASDAQ listing standards.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing status rather than financial performance.
Material Changes
- Board Resignation: Thomas M. Wittenschlaeger voluntarily resigned as a director, Chairman of the Board, Chairman of the Corporate Governance and Nominating Committee, and member of the Audit and Compensation Committees effective May 14, 2012.
- Leadership Appointment: Bernhard Bruscha, a current board member and the company's largest shareholder, was appointed as the new Chairman of the Board on May 14, 2012.
- Listing Compliance: The resignation caused the Audit Committee to fall below the required minimum of three independent directors, violating NASDAQ Listing Rule 5605(c)(2)(A).
Outlook, Risks, and Contingencies
Delisting Risk and Cure Period: The company notified NASDAQ of the non-compliance. Under NASDAQ Listing Rule 5605(c)(4)(B), Lantronix has until the earlier of its next annual shareholders' meeting or May 14, 2013, to regain compliance. If the annual meeting is held on or before November 10, 2012, the deadline is November 10, 2012.
Management Plan: The Board intends to identify candidates to replace Mr. Wittenschlaeger and appoint a new independent director before the expiration of the cure period to satisfy NASDAQ requirements.
Investor Verification Checklist
- Verify the date of the next annual shareholders' meeting to determine the exact deadline for regaining NASDAQ compliance.
- Confirm the appointment of a new independent director to the Audit Committee to resolve the listing deficiency.
- Review the attached resignation letter (Exhibit 17.1) for any undisclosed reasons regarding Mr. Wittenschlaeger's departure.
- Monitor future filings for updates on the Board composition and independence status.